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Abstract
BACKGROUND: Weekly consumption of iron supplementation is preferred to daily consumption of iron 
supplementation because of its minimal side effects and higher level of compliance. 
AIM: This study is to compare the maternal outcomes in pregnant women with daily and weekly consumption of iron 
supplementation in coastal region.
METHODS: This prospective cohort study was conducted from July 2018 to January 2019 in Belawan Health Center 
and Medan Deli Health Center. Sixty-two pregnant women who met inclusion and exclusion criteria were given iron 
supplement everyday (Group 1, n = 29) and twice a week (Group 2, n = 33). Hemoglobin levels, hematocrit, and 
ferritin serum are tested before starting the iron supplementation. All numerical data were analyzed using t-test.
RESULTS: There is no significant difference in mean hemoglobin and hematocrit before and after iron supplementation 
p = 0.222 and p = 0.793, respectively, however, decreasing level of ferritin serum from 41.21 to 26.29 ng/ml (p = 0.001) 
is found. Hemoglobin, hematocrit, and ferritin serum means, before and after supplementation were not statistically 
different between daily and weekly group (p = 0.421, p = 0.197, p = 0.917).
CONCLUSION: To prevent iron deficiency anemia in pregnant women, weekly or daily iron supplementation show 
similar effectiveness although continuous consumption of iron supplementation during breastfeeding period is 
needed to restore iron loss during pregnancy.
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Introduction
Iron deficiency anemia has been a common 
nutritional problem in pregnant women; it is due to 
increasing iron requirements in pregnant women, 
especially in the second and third trimesters [1]. 
Iron deficiency anemia increases the risk of post-
partum hemorrhage that causes maternal mortality in 
Indonesia.
Therefore, the Indonesian government made a 
policy of giving daily 90 iron tablets for 3 months during 
antenatal care [2]. Meta-analysis of Haider et al. showed 
that iron tablet supplementation increases the maternal 
hemoglobin concentration of 0.46 g/dl compared 
to controls and effectively reduces the risk of iron 
deficiency anemia [3].
However, it is important to consider that the 
absorption of intestine to iron is limited; therefore, the 
supplementation is not only useless but also increasing 
side effects [4]. Recent studies found that daily iron 
supplements increase lipid peroxidation [5] and reduce 
zinc absorption [6], [7]. Frazer et al. showed that periodic 
iron supplementation enhances mucosal healing and 
increase iron absorption [8].
Several studies have been conducted to 
find alternative regimens for iron administration in 
pregnant women that will minimize side effects and 
affect compliance [9], [10], [11], [12]. Recent studies 
showed that weekly iron supplementation has the 
similar effectiveness as daily iron supplementation in 
non-anemic pregnant women [12] and reduce the risk 
of high hemoglobin concentration in the middle and 
end of pregnancy [13]. Mukhopadhyay et al. stated 
that weekly iron supplementation was an effective 
choice for prophylaxis in non-anemic pregnant women, 
but is not beneficial in anemic women [14]. Majority of 
people living in coastal areas have low socio-economic 
levels [15]. This study aims to compare the maternal 
outcomes between pregnant women with daily and 
weekly iron supplementation in Indonesian coastal 
region.
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Materials and Methods
Samples and data collection
This prospective cohort study was conducted 
from July 2018 to January 2019 involving 201 pregnant 
women who came to Belawan Health Center and 
Medan Deli Health Center. The inclusion criteria were 
non anemic pregnant women with gestational age 
of 13–28 weeks, pregnant women who approved 
informed consent and could provide contact person for 
follow-up. The exclusion criteria were pregnant women 
with malignancies and multiple pregnancies.
Blood count and ferritin serum level were 
examined at the first visit. Samples were divided into two 
groups. The first group was given daily iron supplements 
while the second group was given iron supplements 
twice a week on Tuesday and Friday for 3 months. One 
iron tablet contains 180 mg of ferrous fumarate and 
400 g of folic acid. The tablets were manufactured by 
PhaprosRx. After 3 months, the patients were contacted 
by mobile phone or through their midwife to come to the 
Health Center for routine blood evaluation and ferritin 
serum levels. The blood samples were examined by 
Prodia Laboratory using Sysmex XN 1000.
Statistical analysis
Data were analyzed using SPSS software. Age, 
gestational age, history of pregnancy, and hematological 
value of the daily and weekly supplementation groups 
were analyzed using independent-t test. Blood count and 
ferritin serum levels before and after supplementation 
were analyzed using paired-t test. Significant value was 
set at p < 0.05.
Results
The area of research in our study is about 
21.82 km2 with a height about 3 m above sea levels. 
The northern part of the area is directly adjacent to the 
Malacca Strait. The mean population density is 4499 
people/km2 [16]. Average net income per month of the 
population in the research area was less than 2 million 
rupiah which is the average income in Indonesia [17].
From 201 pregnant women included in this 
study, only 62 subjects could be admitted for the 
evaluation of iron supplementation for 3 months based 
on selection criteria. The daily iron supplementation 
groups were 29 pregnant women (46.77%) and the 
weekly supplementation groups was 33 pregnant 
women (53.23%). Subject characteristics are shown in 
Table 1. The mean age of subjects was 27.87 ± 5.96 
years with the youngest age was 19 years and the 
oldest age was 40 years. The mean gestational age 
was 21.02 ± 4.90 weeks with the youngest gestational 
age was 12 weeks and the oldest was 31 weeks. There 
were no significant differences in age and gestational 
age between the daily iron supplementation groups and 
the weekly groups (p > 0.05).
Table 1: Characteristics of the subjects
Characteristics Daily (n = 29) Weekly (n = 33) p value
Age (years) 28.55 ± 6.06 27.27 ± 5.90 0.404
Gestational age (weeks) 20.46 ± 4.54 21.50 ± 5.22 0.419
History of pregnancy
Primigravida 7 (24.14) 9 (27.27)
Secundigravida 12 (41.38) 10 (30.30)
Multigravida 9 (31.03) 13 (39.39)
Grand emultigravida 1 (3.45) 1 (3.03)
Initial hematological value
Hemoglobin (g/dl) 11.60 ± 0.95 11.33 ± 0.96 0.272
Hematocrit (%) 34.20 ± 2.41 33.76 ± 2.02 0.572
Platelet (x 103 /µl) 309.52 ± 50.89 297.82 ± 60.33 0.416
Leukocytes (x 103 /µl) 10.83 ± 2.53 10.24 ± 2.29 0.341
ESR (mm/hour) 60.97 ± 29.05 56.00 ± 19.29 0.438
Serum ferritin (ng/ml) 43.32 ± 32.72 39.35 ± 35.17 0.648
Regarding the history of pregnancy, 16 
subjects (25.81%) were primigravida, 22 subjects 
(35.48%) were secundigravida, 22 subjects (35.48%) 
were multigravida, and two subjects (3.23%) were 
grand emultigravida. Before iron supplementation, there 
were no significant differences in the mean hemoglobin 
levels, hematocrit, and serum ferritin between the daily 
and weekly iron supplementation groups (p > 0.05). 
Of all subjects enrolled in this study, there was no 
significant difference between the mean hemoglobin 
levels before iron supplementation (11.46 ± 0.96 g/dl) 
and after three months of supplementation (11.30 ± 
0.85 g/dl) (p = 0.222).
The mean hematocrit before iron 
supplementation was 34.00 ± 2.61% and the mean 
hematocrit after iron supplementation was 34.11 ± 
2.56% (p = 0.793). The mean ferritin serum levels after 
iron supplementation was lower (26.29 ± 21.84 ng/ml) 
compared to those before iron supplementation (41.21 
± 33.82 ng/ml) (p = 0.001).
In the daily group, there were no significant 
differences in the mean hemoglobin levels 
before and after iron supplementation (11.60 g/dl 
vs. 11.33 g/dl, p = 0.141), as well as the weekly group 
(11.33 g/dl vs. 11.27 g/dl, p = 0.744) (Table 2). However, 
the mean ferritin serum levels after iron supplementation 
was significantly lower compared to those before 
supplementation (27.90 ng/ml vs. 43.32 ng/ml, p = 0.013). 
As the daily group, the mean of ferritin serum before 
supplementation in weekly group was lower compared 
to those after supplementation (24.87 ng/ml vs. 39.35 
ng/ml), but not statistically different (p = 0.070). The 
differences of the mean hemoglobin levels and the 
difference of the mean ferritin serum levels between 
daily and weekly group were not statistically different 
(0.27 vs. 0.06 g/dl, p = 0.421) for hemoglobin 
concentration and 15.42 vs. 14.47 ng/ml, p = 0.917) for 
ferritin serum (Table 2).
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Discussion
Iron supplementation is highly recommended 
to prevent iron deficiency anemia in pregnant women. 
These were due to increasing iron requirement for 
the growth of the placenta and fetus [18]. This study 
aims to compare the anemia level of pregnant women 
with daily and weekly iron supplementation who 
attended Belawan Health Center and Medan Deli 
Health Center. Our study showed decreasing level in 
hemoglobin before and after iron supplementation in 
the daily group as well as the weekly group, but it was 
not statistically significant. The change of hemoglobin 
concentration was not statistically different between 
daily and weekly groups (p = 0.421) A recent study 
found that in non-anemic pregnant women, the weekly 
iron supplementation was an effective alternative to 
the daily supplementation for preventing anemia and 
iron deficiency [19]. The weekly iron supplementation 
benefits pregnant women in serum iron and total iron 
binding capacity (TIBC) [20]; therefore, iron deficiency 
anemia in pregnant women can be prevented.
The difference of ferritin serum before and 
after iron supplementation between daily and weekly 
group was not statistically different (p = 0.917). This 
result was similar with the study by Goonewardene and 
Senadheera [12], [19]. Several studies showed changes 
of ferritin serum level after iron supplementation in daily 
and weekly group [14], [20], [21], [22]. Sipra et al. found 
that ferritin serum levels increased in both groups. 
Zamani et al. and Mukhopadhyay et al. study showed 
increasing level of ferritin serum in the daily group and 
decreasing level of ferritin serum level in weekly group.
Our study shows decreasing level in the mean 
of ferritin serum level before and after supplementation 
in both groups (p = 0.001); however, the level did not 
reach the minimum standard level of ferritin serum 
(12 ng/ml) [23]. Decreasing level of ferritin serum was 
physiological due to the hemodilution process and high 
demands of the iron, especially in mid-trimester of 
pregnancy [24].
However, a recent study found that pregnant 
women in all trimesters had low level of ferritin 
serum [25]. The limitation of our study is small 
number of subjects that is being analyzed due to the 
geographical factor of area where most of them live in 
fishing villages that have limited access to the clinic. 
The other obstacles are the loss of communication for 
continuous evaluation and lack of family supports.
Conclusion
In our study, we found that weekly iron 
supplementation was as effective as daily iron 
supplementation in non-anemic pregnant women. 
Therefore, the regimen can be recommended to improve 
the compliance (medical adherence) of the patients, 
especially in coastal region. The iron supplementation 
should be continued during breastfeeding period to 
restore iron loss during pregnancy.
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